PMID- 28612994 OWN - NLM STAT- MEDLINE DCOM- 20180417 LR - 20180821 IS - 2059-2310 (Electronic) IS - 2059-2302 (Linking) VI - 90 IP - 3 DP - 2017 Sep TI - Strain-based HLA association analysis identified HLA-DRB1*09:01 associated with modern strain tuberculosis. PG - 149-156 LID - 10.1111/tan.13070 [doi] AB - Tuberculosis (TB) occurs as a result of complex interactions between the host immune system and pathogen virulence factors. Human leukocyte antigen (HLA) class II molecules play an important role in the host immune system. However, no study has assessed the association between HLA class II genes and susceptibility to TB caused by specific strains. This study investigated the possible association of HLA class II genes with TB caused by modern and ancient Mycobacterium tuberculosis (MTB). The study included 682 patients with TB and 836 control subjects who were typed for HLA-DRB1 and HLA-DQB1 alleles. MTB strains were classified using a large sequence polymorphism typing method. Association analysis was performed using common HLA alleles and haplotypes in different MTB strains. HLA association analysis of patients infected with modern MTB strains showed significant association for HLA-DRB1*09:01 (odds ratio [OR] = 1.82; P-value = 9.88 x 10(-4) ) and HLA-DQB1*03:03 alleles (OR = 1.76; P-value = 1.31 x 10(-3) ) with susceptibility to TB. Haplotype analysis confirmed that these alleles were in strong linkage disequilibrium and did not exert an interactive effect. Thus, the results of this study showed an association between HLA class II genes and susceptibility to TB caused by modern MTB strains, suggesting the importance of strain-specific analysis to determine susceptibility genes associated with TB. CI - (c) 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. FAU - Toyo-Oka, L AU - Toyo-Oka L AUID- ORCID: 0000-0002-9738-2441 AD - Medical Genetics Center, Medical Life Science Institute, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand. AD - Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. FAU - Mahasirimongkol, S AU - Mahasirimongkol S AD - Medical Genetics Center, Medical Life Science Institute, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand. FAU - Yanai, H AU - Yanai H AD - Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), Kiyose, Japan. AD - Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (JATA), Kiyose, Japan. FAU - Mushiroda, T AU - Mushiroda T AD - Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. FAU - Wattanapokayakit, S AU - Wattanapokayakit S AD - Medical Genetics Center, Medical Life Science Institute, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand. FAU - Wichukchinda, N AU - Wichukchinda N AD - Medical Genetics Center, Medical Life Science Institute, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand. FAU - Yamada, N AU - Yamada N AD - Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (JATA), Kiyose, Japan. FAU - Smittipat, N AU - Smittipat N AD - Tuberculosis Research Laboratory, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand Science Park (TSP), Pathum Thani, Thailand. FAU - Juthayothin, T AU - Juthayothin T AD - Tuberculosis Research Laboratory, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand Science Park (TSP), Pathum Thani, Thailand. FAU - Palittapongarnpim, P AU - Palittapongarnpim P AD - Department of Microbiology, Faculty of Science, Mahidol University, Bangkok, Thailand. FAU - Nedsuwan, S AU - Nedsuwan S AD - Chiangrai Prachanukroh Hospital, Ministry of Public Health, Chiang Rai, Thailand. FAU - Kantipong, P AU - Kantipong P AD - Chiangrai Prachanukroh Hospital, Ministry of Public Health, Chiang Rai, Thailand. FAU - Takahashi, A AU - Takahashi A AD - Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. FAU - Kubo, M AU - Kubo M AD - Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. FAU - Sawanpanyalert, P AU - Sawanpanyalert P AD - Health Technical Office, Ministry of Public Health, Nonthaburi, Thailand. FAU - Tokunaga, K AU - Tokunaga K AD - Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. LA - eng PT - Clinical Trial PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20170614 PL - England TA - HLA JT - HLA JID - 101675570 RN - 0 (HLA-DRB1 Chains) RN - 0 (HLA-DRB1*09:01 antigen) SB - IM MH - Adult MH - Aged MH - Female MH - *Genetic Predisposition to Disease MH - HLA-DRB1 Chains/*genetics/immunology MH - Humans MH - *Linkage Disequilibrium MH - Male MH - Middle Aged MH - *Mycobacterium tuberculosis MH - Thailand/epidemiology MH - Tuberculosis/epidemiology/*genetics OTO - NOTNLM OT - Mycobacterium tuberculosis OT - HLA-DQB1 OT - HLA-DRB1 OT - human leukocyte antigens OT - pathogen-specific association OT - tuberculosis EDAT- 2017/06/15 06:00 MHDA- 2018/04/18 06:00 CRDT- 2017/06/15 06:00 PHST- 2017/01/23 00:00 [received] PHST- 2017/05/18 00:00 [revised] PHST- 2017/05/22 00:00 [accepted] PHST- 2017/06/15 06:00 [pubmed] PHST- 2018/04/18 06:00 [medline] PHST- 2017/06/15 06:00 [entrez] AID - 10.1111/tan.13070 [doi] PST - ppublish SO - HLA. 2017 Sep;90(3):149-156. doi: 10.1111/tan.13070. Epub 2017 Jun 14.